Application of drug delivery technologies in lead candidate selection and optimization

Drug Discovery Today
Mahesh V Chaubal

Abstract

Formulation development during early drug discovery and lead optimization, involves several challenges including limited drug supply, the need for rapid turnaround, and limited development time. It is also desirable to develop initial formulations that will be representative of final commercial formulations. Nanoparticles offer a unique platform for the formulation of poorly soluble drugs - such formulations can be injected (intravenous, subcutaneous, intramuscular), as well as administered through other routes, such as oral, ocular and inhalation. Thus, a single formulation can be used to test and eventually develop multiple dosage forms. Furthermore, nanoparticles offer the opportunity for high drug loading, for low potency compounds, and thus support toxicological evaluation of such compounds.

References

Jun 1, 1994·Journal of Clinical Pharmacology·B H BoedekerD H Haynes
Jan 1, 1997·Critical Reviews in Therapeutic Drug Carrier Systems·D O Thompson
Dec 28, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·K D OstranderD M Bondanza
Feb 25, 2000·Journal of Pharmaceutical Sciences·S Venkatesh, R A Lipper
Sep 8, 2001·Drug Discovery Today·S J.F. Macdonald, P W. Smith
Sep 29, 2001·Advanced Drug Delivery Reviews·C J Porter, W N Charman
Jul 13, 2002·Journal of Pharmaceutical Sciences·Xue-Qing ChenSrini Venkatesh
Jul 18, 2002·Nature Reviews. Drug Discovery·Olof Ramström, Jean-Marie Lehn
Oct 3, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Neil Parrott, Thierry Lavé
Nov 5, 2002·Nature Reviews. Drug Discovery·Jürgen Bajorath
Feb 21, 2003·International Journal of Pharmaceutics·Yung-Chi LeeBrian Samas
Feb 21, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elaine Merisko-LiversidgeEugene R Cooper
Feb 28, 2003·Journal of Health Economics·Joseph A DiMasiHenry G Grabowski
Mar 4, 2003·Nature Reviews. Drug Discovery·H Mario GeysenRichard Wagner
Apr 25, 2003·Journal of Pharmaceutical Sciences·Venkatramana M Rao, Valentino J Stella
Jul 8, 2003·Clinical Pharmacokinetics·Albert J ten TijeAlex Sparreboom
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joshua WilliamsEvan Unger
Oct 23, 2003·Drug Development and Industrial Pharmacy·Katsutoshi NakamuraShigeharu Yokohama
Oct 31, 2003·Critical Reviews in Therapeutic Drug Carrier Systems·Sundeep Sethia, Emilio Squillante
Dec 4, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Paul R LockmanDavid D Allen
Dec 9, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Johanna Mercke OdebergPeter Höglund
Feb 27, 2004·Pharmaceutical Research·Emily C Ware, D Robert Lu

❮ Previous
Next ❯

Citations

May 30, 2008·Pharmaceutical Research·Mahesh V Chaubal, Carmen Popescu
Oct 6, 2007·Expert Opinion on Drug Metabolism & Toxicology·Jianling WangDejan Bojanic
Mar 29, 2013·Expert Opinion on Drug Delivery·Sonali S Bharate, Ram A Vishwakarma
Jan 7, 2014·Expert Opinion on Drug Discovery·Sorin Emilian Leucuta
Nov 22, 2005·Expert Opinion on Drug Delivery·Isabel Gomez-Orellana
Feb 26, 2013·Journal of Pharmaceutical Sciences·Jaime SalazarJan P Möschwitzer
Sep 25, 2012·International Journal of Pharmaceutics·Jan P Möschwitzer
Jan 12, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jaime SalazarJan P Möschwitzer
Mar 23, 2011·International Journal of Pharmaceutics·Elizabeth KwongAllen C Templeton
Oct 15, 2009·International Journal of Pharmaceutics·C E Mora-HuertasA Elaissari
Dec 22, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Martin KuentzDavid P Elder
Dec 29, 2004·International Journal of Pharmaceutics·Qing WangIsmael J Hidalgo
Sep 26, 2006·Journal of Pharmaceutical and Biomedical Analysis·Linda Hitchingham, V Hayden Thomas
Feb 2, 2008·The Journal of Pharmacy and Pharmacology·Joseph A NicolazzoSusan A Charman
Oct 3, 2006·Journal of Molecular Modeling·Gregor MlinsekTom Solmajer
Feb 7, 2013·Pharmacological Reviews·Hywel D WilliamsChristopher J H Porter
Aug 6, 2020·Pharmaceutics·Thao T D Tran, Phuong H L Tran
Jan 1, 2014·Journal of Pharmaceutics·Jaime SalazarJan P Möschwitzer
Aug 24, 2018·Pharmaceutics·Maria Rosa GigliobiancoPiera Di Martino
Sep 24, 2008·Journal of Combinatorial Chemistry·Matthias TreuAlexander Stadler
May 6, 2008·Journal of Agricultural and Food Chemistry·Tze Loon NeohTakeshi Furuta
Dec 2, 2008·Molecular Pharmaceutics·Dwayne T FriesenJ A S Nightingale

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Jochen MaasGerrit Hauck
Pharmaceutical Science & Technology Today
G M Barratt
International Journal of Pharmaceutics
Ping Li, Luwei Zhao
© 2022 Meta ULC. All rights reserved